Pink Sheet is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

In Brief: Procter & Gamble

This article was originally published in The Tan Sheet

Executive Summary

Procter & Gamble: Submits comments on FDA's proposed nutrient content and health claims regs ("The Tan Sheet" Jan. 1, p. 15). Referring to the agency's proposal to allow unlisted synonyms on labeling as long as the approved term also appears. P&G recommended that "FDA adopt a more flexible policy by making the use of the approved term optional" because "use of two nutrient content claims may make the label crowded and confusing to consumers." The comments suggest making use of the listed synonym an optional safe harbor...
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS085955

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel